Abstract
Intraductal carcinoma (DCIS) was once an uncommon disease. Today, DCIS represents 20-30% of breast cancers that are diagnosed. Mammography has been the gold standard in detecting DCIS, however recent evidence demonstrates that magnetic resonance imaging (MRI) may be superior to mammography in detecting DCIS. In addition, MRI may be able to detect high grade, mammographically occult DCIS that are more likely to progress on to become invasive carcinoma.
Keywords: Breast Cancer, DCIS, Detection, Mammography, MRI
Current Cancer Therapy Reviews
Title:Imaging Intraductal Carcinoma
Volume: 8 Issue: 3
Author(s): Susan Weinstein
Affiliation:
Keywords: Breast Cancer, DCIS, Detection, Mammography, MRI
Abstract: Intraductal carcinoma (DCIS) was once an uncommon disease. Today, DCIS represents 20-30% of breast cancers that are diagnosed. Mammography has been the gold standard in detecting DCIS, however recent evidence demonstrates that magnetic resonance imaging (MRI) may be superior to mammography in detecting DCIS. In addition, MRI may be able to detect high grade, mammographically occult DCIS that are more likely to progress on to become invasive carcinoma.
Export Options
About this article
Cite this article as:
Weinstein Susan, Imaging Intraductal Carcinoma, Current Cancer Therapy Reviews 2012; 8 (3) . https://dx.doi.org/10.2174/157339412802653119
DOI https://dx.doi.org/10.2174/157339412802653119 |
Print ISSN 1573-3947 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6301 |
Call for Papers in Thematic Issues
Advancements in Lipid Nanoparticle Delivery Systems for mRNA Therapeutics
The thematic issue "Advancements in Lipid Nanoparticle Delivery Systems for mRNA Therapeutics" aims to explore cutting-edge developments and innovative strategies in the field of lipid nanoparticle (LNP) technology, particularly focusing on its application in mRNA delivery. This topic has gained unprecedented attention and urgency in the wake of the COVID-19 ...read more
Current Progress in Protein Degradation and Cancer Therapy
Targeted Protein Degradation is gaining momentum in cancer therapy; it facilitates targeting undruggable proteins, overcomes cancer resistance, and avoids undesirable side effects. Thus small molecule degraders have emerged as novel therapeutic strategies. Targeted protein degradation (TPD), the process of eliminating a protein of interest holds a great promise for the ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Docking and Molecular Dynamics Study on the Inhibitory Activity of Novel Inhibitors on Epidermal Growth Factor Receptor (EGFR)
Medicinal Chemistry The Role of MicroRNAs in Lung Cancer: Implications for Diagnosis and Therapy
Current Molecular Medicine Silencing GPX3 Expression Promotes Tumor Metastasis in Human Thyroid Cancer
Current Protein & Peptide Science Nanosized Tamoxifen-Porphyrin-Glucose [TPG] Conjugate: Novel Selective Anti-breast-cancer Agent, Synthesis and In Vitro Evaluations
Medicinal Chemistry Anticancer Compounds from Cyanobacteria and their Implications in Apoptosis
Current Protein & Peptide Science Drug Metabolism and Pharmacokinetic Diversity of Ranunculaceae Medicinal Compounds
Current Drug Metabolism The Cellular and Molecular Basis of Health Benefits of Grape Seed Proanthocyanidin Extract
Current Pharmaceutical Biotechnology FBP1, A Tumor Suppressor and Negative Regulator of Glycolysis, was Epigenetically Silenced in Pancreatic Cancer
Current Signal Transduction Therapy Variability of Biological Activities of Limonoids Derived from Plant Sources
Mini-Reviews in Organic Chemistry Drug Delivery Systems and Combination Therapy by Using Vinca Alkaloids
Current Topics in Medicinal Chemistry Relevance of the Salvage Pathway to N-Hexanoylsphingosine Metabolic Downregulation in Human Neurotumor Cells: Implications for Apoptosis
Drug Metabolism Letters Inflammation and Antiangiogenesis in Cancer
Current Medicinal Chemistry Analgesic Effects and Assays of Controlled-Release Tramadol and O-Desmethyltramadol in Cancer Patients with Pain
Current Pharmaceutical Biotechnology FoxO Proteins: Regulation and Molecular Targets in Liver Cancer
Current Medicinal Chemistry Oxidovanadium(IV) Complex Disrupts Mitochondrial Membrane Potential and Induces Apoptosis in Pancreatic Cancer Cells
Anti-Cancer Agents in Medicinal Chemistry Tackling Chronic Pain and Inflammation through the Purinergic System
Current Medicinal Chemistry Identification of Cancerlectins By Using Cascade Linear Discriminant Analysis and Optimal g-gap Tripeptide Composition
Current Bioinformatics Magnetic Resonance Nano-Theranostics for Glioblastoma Multiforme
Current Pharmaceutical Design Nucleic Acid-Based Therapeutics for Glioblastoma
Anti-Cancer Agents in Medicinal Chemistry Revisiting the ABCs of Multidrug Resistance in Cancer Chemotherapy
Current Pharmaceutical Biotechnology